Literature DB >> 8450249

Demonstration of Chlamydia pneumoniae in atherosclerotic lesions of coronary arteries.

C C Kuo1, A Shor, L A Campbell, H Fukushi, D L Patton, J T Grayston.   

Abstract

Chlamydia pneumoniae is a human respiratory pathogen that causes acute respiratory disease and approximately 10% of community-acquired pneumonia. The infections are geographically widespread. Antibody prevalence studies have shown that virtually everyone is infected with the C. pneumoniae organisms at some time and that reinfection is common. In addition to respiratory disease, seroepidemiologic studies have shown an association of this organism with coronary artery disease. C. pneumoniae was detected in coronary artery atheromas by immunocytochemistry (15/36) and by polymerase chain reaction (PCR) (13/30) in 20 of 36 autopsy cases from Johannesburg, South Africa. Sequence analysis of the C. pneumoniae rRNA genes amplified by PCR confirmed that the amplified gene products were C. pneumoniae. Electron microscopy revealed typical pear-shaped C. pneumoniae elementary bodies in 6 of 21 atheromatous plaques. These findings support the seroepidemiologic studies and offer further evidence that C. pneumoniae may be involved in the atherosclerotic process.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8450249     DOI: 10.1093/infdis/167.4.841

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  127 in total

Review 1.  Molecular diagnosis of Chlamydia pneumoniae infection.

Authors:  J Boman; C A Gaydos; T C Quinn
Journal:  J Clin Microbiol       Date:  1999-12       Impact factor: 5.948

2.  Multicenter comparison trial of DNA extraction methods and PCR assays for detection of Chlamydia pneumoniae in endarterectomy specimens.

Authors:  P Apfalter; F Blasi; J Boman; C A Gaydos; M Kundi; M Maass; A Makristathis; A Meijer; R Nadrchal; K Persson; M L Rotter; C Y Tong; G Stanek; A M Hirschl
Journal:  J Clin Microbiol       Date:  2001-02       Impact factor: 5.948

Review 3.  Chlamydia pneumoniae and atherosclerosis.

Authors:  J D Rutherford
Journal:  Curr Atheroscler Rep       Date:  2000-05       Impact factor: 5.113

4.  cDNA array analysis of altered gene expression in human endothelial cells in response to Chlamydia pneumoniae infection.

Authors:  B K Coombes; J B Mahony
Journal:  Infect Immun       Date:  2001-03       Impact factor: 3.441

Review 5.  Chlamydia pneumoniae in arteries: the facts, their interpretation, and future studies.

Authors:  D Taylor-Robinson; B J Thomas
Journal:  J Clin Pathol       Date:  1998-11       Impact factor: 3.411

6.  Relation of Chlamydia pneumoniae serology to mortality and incidence of ischaemic heart disease over 13 years in the caerphilly prospective heart disease study.

Authors:  D P Strachan; D Carrington; M A Mendall; L Ballam; J Morris; B K Butland; P M Sweetnam; P C Elwood
Journal:  BMJ       Date:  1999-04-17

7.  Inhibition of Chlamydia pneumoniae replication in human aortic smooth muscle cells by gamma interferon-induced indoleamine 2, 3-dioxygenase activity.

Authors:  L G Pantoja; R D Miller; J A Ramirez; R E Molestina; J T Summersgill
Journal:  Infect Immun       Date:  2000-11       Impact factor: 3.441

8.  Characterization of Chlamydia pneumoniae persistence in HEp-2 cells treated with gamma interferon.

Authors:  L G Pantoja; R D Miller; J A Ramirez; R E Molestina; J T Summersgill
Journal:  Infect Immun       Date:  2001-12       Impact factor: 3.441

Review 9.  Chlamydia pneumoniae and atherosclerosis: critical assessment of diagnostic methods and relevance to treatment studies.

Authors:  Jens Boman; Margaret R Hammerschlag
Journal:  Clin Microbiol Rev       Date:  2002-01       Impact factor: 26.132

10.  Is Chlamydia pneumoniae infection a risk factor for age related macular degeneration?

Authors:  O Ishida; H Oku; T Ikeda; M Nishimura; K Kawagoe; K Nakamura
Journal:  Br J Ophthalmol       Date:  2003-05       Impact factor: 4.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.